1. Home
  2. MDGL vs TPG Comparison

MDGL vs TPG Comparison

Compare MDGL & TPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDGL
  • TPG
  • Stock Information
  • Founded
  • MDGL 2011
  • TPG 1992
  • Country
  • MDGL United States
  • TPG United States
  • Employees
  • MDGL N/A
  • TPG N/A
  • Industry
  • MDGL Biotechnology: Pharmaceutical Preparations
  • TPG Investment Managers
  • Sector
  • MDGL Health Care
  • TPG Finance
  • Exchange
  • MDGL Nasdaq
  • TPG Nasdaq
  • Market Cap
  • MDGL 9.6B
  • TPG 8.6B
  • IPO Year
  • MDGL N/A
  • TPG 2022
  • Fundamental
  • Price
  • MDGL $442.69
  • TPG $54.47
  • Analyst Decision
  • MDGL Strong Buy
  • TPG Buy
  • Analyst Count
  • MDGL 12
  • TPG 14
  • Target Price
  • MDGL $521.09
  • TPG $65.69
  • AVG Volume (30 Days)
  • MDGL 305.2K
  • TPG 1.6M
  • Earning Date
  • MDGL 10-30-2025
  • TPG 11-04-2025
  • Dividend Yield
  • MDGL N/A
  • TPG 3.06%
  • EPS Growth
  • MDGL N/A
  • TPG N/A
  • EPS
  • MDGL N/A
  • TPG N/A
  • Revenue
  • MDGL $515,547,000.00
  • TPG $3,887,230,000.00
  • Revenue This Year
  • MDGL $394.08
  • TPG N/A
  • Revenue Next Year
  • MDGL $61.80
  • TPG $25.02
  • P/E Ratio
  • MDGL N/A
  • TPG N/A
  • Revenue Growth
  • MDGL 3421.98
  • TPG 43.35
  • 52 Week Low
  • MDGL $200.63
  • TPG $37.52
  • 52 Week High
  • MDGL $463.63
  • TPG $72.98
  • Technical
  • Relative Strength Index (RSI)
  • MDGL 55.60
  • TPG 36.44
  • Support Level
  • MDGL $416.29
  • TPG $54.56
  • Resistance Level
  • MDGL $451.02
  • TPG $58.35
  • Average True Range (ATR)
  • MDGL 17.47
  • TPG 2.25
  • MACD
  • MDGL -3.22
  • TPG -0.33
  • Stochastic Oscillator
  • MDGL 44.42
  • TPG 0.85

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

About TPG TPG Inc.

TPG Inc is an alternative asset management firm. It invests across five multi-product platforms namely Capital, Growth, Impact, Real Estate, Market Solutions, and TPG Angelo Gordon. The company focuses on large-scale, control-oriented private equity investments.

Share on Social Networks: